Clinical Trial Update: Fasturtec TLS Treatment / Prophylysis [Phase 4]

View source ↗

Summary

Phase 4 trial of Fasturtec for tumor lysis syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Lysis Syndrome

Drugs mentioned

• Fasturtec (rasburicase)

Snippet

Sponsor: Sanofi | Conditions: Tumor Lysis Syndrome | Phase 4 | Status: COMPLETED